Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Selik, R. M.    Ward, J. W.    Related Articles in PubMed    PubMed Citation    PubMed

BRIEF COMMUNICATION

Trends in Infectious Diseases and Cancers among Persons Dying of HIV Infection in the United States from 1987 to 1992

Richard M. Selik, MD; Susan Y. Chu, PhD; and John W. Ward, MD

15 December 1995 | Volume 123 Issue 12 | Pages 933-936

Objective: To determine trends in the relative frequency of infectious diseases and cancers among U.S. residents dying of human immunodeficiency virus (HIV) infection.

Data Source: National multiple-cause mortality data for 1987 to 1992 compiled from death certificates.

Subjects: Deaths reported with HIV infection as the underlying cause and with nonunderlying causes that could be secondary to HIV infection.

Data Analysis: Trends in the annual percentage of deaths associated with each infectious disease or cancer that accounted for at least 1.0% of all HIV-related deaths.

Results: From 1987 to 1992, the percentage of HIV-related deaths associated with the following diseases decreased: pneumocystosis, from 32.5% to 13.8%; cryptococcosis, from 7.7% to 5.0%; and candidiasis, from 2.3% to 1.7%. The percentage of deaths associated with the following diseases increased: nontuberculous mycobacteriosis, from 6.7% to 12.2%; cytomegalovirus disease, from 5.2% to 9.9%; bacterial septicemia, from 9.0% to 11.5%; non-Hodgkin lymphoma, from 3.9% to 5.7%; tuberculosis, from 2.9% to 4.1%; progressive multifocal leukoencephalopathy, from 0.8% to 1.9%; bacterial pneumonia, from 1.2% to 2.1%; and cryptosporidiosis or isosporiasis, from 0.7% to 1.2%. The percentages of deaths associated with toxoplasmosis, Kaposi sarcoma, and pneumonia caused by unspecified organisms had no significant linear trends (ranges from 4.9% to 5.5%, 10.4% to 12.1%, and 17.6% to 18.6%, respectively).

Conclusions: The percentage of HIV-related deaths associated with pneumocystosis has decreased dramatically, probably because of chemoprophylaxis and improved treatment. Pneumonia caused by unspecified organisms has now become the leading secondary cause of death among persons dying of HIV infection. Decreases in the percentages of HIV-related deaths associated with cryptococcosis and candidiasis may reflect the use of new antifungal agents such as fluconazole.

Author and Article Information

From the Centers for Disease Control and Prevention, Atlanta, Georgia.
Acknowledgment: The authors thank Debra L. Hanson, MS, for advice on statistical methods.
Requests for Reprints: Richard M. Selik, MD, Centers for Disease Control and Prevention, Mail-Stop E47, 1600 Clifton Road, Atlanta, GA 30333.
Current Author Addresses: Drs. Selik, Chu, and Ward: Centers for Disease Control and Prevention, Mail-Stop E47, 1600 Clifton Road, Atlanta, GA 30333.

This article has been cited by other articles:

				Q. Zhou, R. A. Gault, T. R. Kozel, and W. J. Murphy Protection from Direct Cerebral Cryptococcus Infection by Interferon-{gamma}-Dependent Activation of Microglial Cells J. Immunol., May 1, 2007; 178(9): 5753 - 5761. [Abstract] [Full Text] [PDF]

				J. A. Sparano, S. Lee, M. G. Chen, T. Nazeer, A. Einzig, R. F. Ambinder, D. H. Henry, J. Manalo, T. Li, and J. H. Von Roenn Phase II Trial of Infusional Cyclophosphamide, Doxorubicin, and Etoposide in Patients With HIV-Associated Non-Hodgkin's Lymphoma: An Eastern Cooperative Oncology Group Trial (E1494) J. Clin. Oncol., April 15, 2004; 22(8): 1491 - 1500. [Abstract] [Full Text] [PDF]

				A J Kvalsvig and D J Unsworth The immunopathogenesis of meningococcal disease J. Clin. Pathol., June 1, 2003; 56(6): 417 - 422. [Abstract] [Full Text] [PDF]

				D. Turner, Y. Schwarz, and I. Yust Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues Eur. Respir. J., February 1, 2003; 21(2): 204 - 208. [Abstract] [Full Text] [PDF]

				M. Cohen, R. G. Hoffman, C. Cromwell, J. Schmeidler, F. Ebrahim, G. Carrera, F. Endorf, C. A. Alfonso, and J. M. Jacobson The Prevalence of Distress in Persons With Human Immunodeficiency Virus Infection Psychosomatics, February 1, 2002; 43(1): 10 - 15. [Abstract] [Full Text]

				G. Abenes, M. Lee, E. Haghjoo, T. Tong, X. Zhan, and F. Liu Murine Cytomegalovirus Open Reading Frame M27 Plays an Important Role in Growth and Virulence in Mice J. Virol., February 15, 2001; 75(4): 1697 - 1707. [Abstract] [Full Text]

				E. CORDERO, J. PACHÓN, A. RIVERO, J. A. GIRÓN, J. GÓMEZ-MATEOS, M. D. MERINO, M. TORRES-TORTOSA, M. GONZÁLEZ-SERRANO, L. ALIAGA, A. COLLADO, et al. Community-Acquired Bacterial Pneumonia in Human Immunodeficiency Virus-Infected Patients . Validation of Severity Criteria Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2063 - 2068. [Abstract] [Full Text]

				J. Xiao, T. Tong, X. Zhan, E. Haghjoo, and F. Liu In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame M43 J. Virol., October 15, 2000; 74(20): 9488 - 9497. [Abstract] [Full Text]

				C. S. Morello, L. D. Cranmer, and D. H. Spector Suppression of Murine Cytomegalovirus (MCMV) Replication with a DNA Vaccine Encoding MCMV M84 (a Homolog of Human Cytomegalovirus pp65) J. Virol., April 15, 2000; 74(8): 3696 - 3708. [Abstract] [Full Text]

				D. Balfe and Z. Mohsenifar Downward Trends in Bronchoscopies Performed Between 1991 and 1997 Chest, July 1, 1999; 116(1): 238 - 242. [Abstract] [Full Text] [PDF]

				M. A. A. Cohen Psychiatric Care in an AIDS Nursing Home Psychosomatics, April 1, 1998; 39(2): 154 - 161. [Abstract] [Full Text]

				F. Laurent, M. F. Kagnoff, T. C. Savidge, M. Naciri, and L. Eckmann Human Intestinal Epithelial Cells Respond to Cryptosporidium parvum Infection with Increased Prostaglandin H Synthase 2 Expression and Prostaglandin E2 and F2alpha Production Infect. Immun., April 1, 1998; 66(4): 1787 - 1790. [Abstract] [Full Text] [PDF]

				Palliative Care and HIV, Part II: Systemic Manifestations and Late-Stage Issues AIDS Clinical Care, April 1, 1996; 1996(401): 1 - 1. [Full Text]

				What Are Patients with HIV Dying Of? AIDS Clinical Care, February 1, 1996; 1996(201): 6 - 6. [Full Text]